| Literature DB >> 26981129 |
Ana Carolina Irioda1, Rafael Cassilha2, Larissa Zocche3, Julio Cesar Francisco3, Ricardo Correa Cunha3, Priscila Elias Ferreira3, Luiz Cesar Guarita-Souza4, Reginaldo Justino Ferreira3, Bassam Felipe Mogharbel3, Venkata Naga Srikanth Garikipati5, Daiany Souza3, Mirian Perlingeiro Beltrame6, Katherine Athayde Teixeira de Carvalho1.
Abstract
Aim. The effects of cryopreservation on adipose tissue-derived mesenchymal stem cells are not clearly documented, as there is a growing body of evidence about the importance of adipose-derived mesenchymal stem cells for regenerative therapies. The aim of this study was to analyze human adipose tissue-derived mesenchymal stem cells phenotypic expression (CD34, CD45, CD73, CD90, CD105, and CD49d), colony forming unit ability, viability, and differentiation potential before and after cryopreservation. Materials and Methods. 12 samples of the adipose tissue were collected from a healthy donor using the liposuction technique. The cell isolation was performed by enzymatic digestion and then the cells were cultured up to passage 2. Before and after cryopreservation the immunophenotype, cellular viability analysis by flow cytometer, colony forming units ability, differentiation potential into adipocytes and osteoblasts as demonstrated by Oil Red O and Alizarin Red staining, respectively. Results. The immunophenotypic markers expression was largely preserved, and their multipotency was maintained. However, after cryopreservation, the cells decreased α4-integrin expression (CD49d), cell viability, and number of colony forming units. Conclusions. These findings suggest that ADMSC transplanted after cryopreservation might compromise the retention of transplanted cells in the host tissue. Therefore, further studies are warranted to standardize protocols related to cryopreservation to attain full benefits of stem cell therapy.Entities:
Year: 2016 PMID: 26981129 PMCID: PMC4770156 DOI: 10.1155/2016/2562718
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Panel of monoclonal antibodies used in this study for immunophenotypic characterization.
| Marker | Clone | Reactivity | Fluorochrome | Function |
|---|---|---|---|---|
| CD34 | 581/CD34 | Human | FITC | Stem cell marker (precursor), also found in hematopoietic progenitor cells, vascular endothelium, and fibroblasts of the same tissue. Probably, it works as a transduction signer and has a function in endothelium specific antigen adhesion. |
|
| ||||
| CD45 (common leukocyte antigen) | HI30 | Human | PE | Leukocytes marker. CD45 proteins are located in all hematopoietic cells, but not in erythrocytes. |
|
| ||||
| CD49d (integrin | 9F10 | Human | PE | Transmembrane glycoprotein, integrin |
|
| ||||
| CD73 (ecto-5′-nucleotidase) | AD2 | Human | PE | It have been suggested that this marker can mediate costimulator signals in the cells T activation and endothelium as well catalyses the dephosphorylation of adenosine monophosphate in adenosine. |
|
| ||||
| CD90 (THy-1) | 5E10 | Human | FITC | The role of interaction in cell-cell and cell-matrix has been speculated, with related neurites growth, nerve regeneration, apoptosis, metaphase, inflammation, and fibrosis. |
|
| ||||
| CD105 (endoglin) | 266 | Human | Purified | Responsiveness modulator of TGF- |
Surface markers expressions before cryopreservation and after thawing.
| Molecular marker | CD34− | CD34+ | CD45− | CD49d+ | CD73+ | CD90+ | CD105+ | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cryopreservation | Before | After | Before | After | Before | After | Before | After | Before | After | Before | After | Before | After |
| Medium | 98.88 | 99.3 | 1.12 | 0.78 | 99.79 | 99.8 | 88.67 | 77.8 | 99.57 | 99.5 | 99.55 | 99.5 | 99.4 | 98.3 |
| Max | 99.86 | 100 | 3.32 | 2.1 | 100 | 100 | 96.38 | 93.1 | 99.94 | 99.9 | 99.97 | 100 | 99.91 | 99.9 |
| Min | 96.98 | 97.9 | 0.14 | 0.03 | 99.27 | 99.6 | 80.15 | 41.6 | 98.51 | 98.5 | 98.15 | 97.5 | 97.87 | 93.9 |
| SD | 1.08 | 0.61 | 1.08 | 0.6 | 0.22 | 0.14 | 6.55 | 14.5 | 0.43 | 0.43 | 0.07 | 0.7 | 0.64 | 2.07 |
|
| ||||||||||||||
|
|
|
|
|
|
|
|
| |||||||
p < 0.05.
Figure 1Surface markers expression of cells before cryopreservation and after thawing. The analysis was done by Cyflogic software 1.2.1. The t-test was done; p < 0.05 was considered significant. The results were p = 0,001.
Figure 2Histograms of ADMSC markers before and after cryopreservation. The grey color represents specific marker and the white color represents an isotype control.
Representation of viability and integrity cells before cryopreservation and after thawing.
| Annexin V | 7-AAD | |||
|---|---|---|---|---|
| Before | After | Before | After | |
| Media | 91.39 | 76.31 | 91.34 | 74.99 |
| Max | 96.2 | 95.83 | 79.29 | 49.21 |
| Min | 75.18 | 52.38 | 95.17 | 95.27 |
| DP | 5.85 | 13.33 | 4.54 | 14.19 |
|
| ||||
|
|
|
| ||
Figure 3Histograms of Annexin V (apoptosis marker) and 7-AAD (viability marker) of the cells before and after cryopreservation. The grey color represents specific marker and the white color represents an isotype control.
Figure 4Adipose differentiated cells after 14 days in induction medium: sample after thawing of cryopreserved cells, phase contrast microscopy, 250x. (a) Presence of fat droplets (stained with Oil Red) in ADMSC cultivated with adipogenic induction medium. (b) Control does not have fat droplets, indicating the undifferentiated cells cultivated with standard medium. Scale (10 μm).
Figure 5Osteogenic differentiated cells after 35 days in osteogenic induction medium: sample after thawing of cryopreserved cells, 250x rise. (a) ADMSC stained with Alizarin Red, demonstrating the presence of calcium in extracellular matrix. (b) Control without matrix demonstration, indicating the undifferentiated cells cultivated with standard culture medium. Scale (10 μm).